Mei Sze Chua

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays
    Mei Sze Chua
    Department of Pediatrics, Stanford University School of Medicine, CCSR, Stanford CA, USA
    Am J Transplant 3:17-22. 2003
  2. ncbi request reprint Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma
    Mei Sze Chua
    Department of Surgery and Asian Liver Center, Stanford University School of Medicine, Stanford, CA, USA
    Mod Pathol 20:76-83. 2007
  3. ncbi request reprint Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma
    Mei Sze Chua
    Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5655, USA
    Anticancer Res 26:1739-43. 2006
  4. doi request reprint Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo
    Wei Wei
    Asian Liver Center, Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5655, USA
    Int J Cancer 126:2426-36. 2010
  5. ncbi request reprint Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression
    Thomas Satterwhite
    Department of Pediatrics, Stanford University School of Medicine, 269 Campus Drive, CCSR, Stanford, California 94305, USA
    Pediatr Transplant 7:53-8. 2003
  6. pmc Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
    Wei Wei
    Asian Liver Center, Department of Surgery, 1201 Welch Road, Stanford University School of Medicine, Stanford, CA 94305, USA
    Mol Cancer 10:16. 2011
  7. doi request reprint N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells
    Xinrui Yan
    Asian Liver Center, Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5655, USA
    Cancer Lett 262:133-42. 2008
  8. pmc Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
    Wei Wei
    Asian Liver Center, Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    Mol Cancer 8:76. 2009
  9. pmc Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2
    Chris K Sun
    Asian Liver Center and Department of Surgery, Stanford University School of Medicine, Stanford University, Stanford, CA 94305 5655, USA
    Neoplasia 13:735-47. 2011
  10. ncbi request reprint Applications of microarrays to renal transplantation: progress and possibilities
    Mei Sze Chua
    Department of Pediatrics, Stanford University School of Medicine, G320, 300 Pasteur Drive, Stanford, CA 94305, USA
    Front Biosci 8:s913-23. 2003

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays
    Mei Sze Chua
    Department of Pediatrics, Stanford University School of Medicine, CCSR, Stanford CA, USA
    Am J Transplant 3:17-22. 2003
    ..The possible relationship between alterations in the expression of this cluster, reduced renal function, the alloimmune process itself, and other influences on the renal transplant awaits further analysis...
  2. ncbi request reprint Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma
    Mei Sze Chua
    Department of Surgery and Asian Liver Center, Stanford University School of Medicine, Stanford, CA, USA
    Mod Pathol 20:76-83. 2007
    ..Its significantly elevated expression in hepatocellular carcinoma could be a useful indicator of tumor aggressiveness and therefore patient prognosis...
  3. ncbi request reprint Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma
    Mei Sze Chua
    Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5655, USA
    Anticancer Res 26:1739-43. 2006
    ..Since gallium is known to accumulate specifically in HCC tumors but not in non-tumor liver, we investigated two gallium compounds, gallium nitrate (GaN) and gallium maltolate (GaM), as potential new agents for treating HCC...
  4. doi request reprint Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo
    Wei Wei
    Asian Liver Center, Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5655, USA
    Int J Cancer 126:2426-36. 2010
    ..Our results suggest that these 3 antagonists of the Tcf4/beta-catenin complex are potential chemotherapeutic agents which may offer a pathway specific option for the clinical management of HCC...
  5. ncbi request reprint Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression
    Thomas Satterwhite
    Department of Pediatrics, Stanford University School of Medicine, 269 Campus Drive, CCSR, Stanford, California 94305, USA
    Pediatr Transplant 7:53-8. 2003
    ....
  6. pmc Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
    Wei Wei
    Asian Liver Center, Department of Surgery, 1201 Welch Road, Stanford University School of Medicine, Stanford, CA 94305, USA
    Mol Cancer 10:16. 2011
    ..Recent studies have identified the Frizzled-7 receptor (FZD7), important for activation of Wnt-mediated signaling, as a potential therapeutic target for HCC and other cancers...
  7. doi request reprint N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells
    Xinrui Yan
    Asian Liver Center, Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5655, USA
    Cancer Lett 262:133-42. 2008
    ..These results are consistent with our earlier clinical observations that NDRG1 is associated with more aggressive tumor behavior, and suggest that NDRG1 may be a potential therapeutic target for HCC...
  8. pmc Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
    Wei Wei
    Asian Liver Center, Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    Mol Cancer 8:76. 2009
    ..Since the Wnt/beta-catenin pathway is essential in HCC carcinogenesis, we studied the inhibition of Wnt-1-mediated signaling as a potential molecular target in HCC...
  9. pmc Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2
    Chris K Sun
    Asian Liver Center and Department of Surgery, Stanford University School of Medicine, Stanford University, Stanford, CA 94305 5655, USA
    Neoplasia 13:735-47. 2011
    ..In conclusion, molecular targeting of GPC3 at the translational level offers an effective option for the clinical management of GPC3-positive HCC patients...
  10. ncbi request reprint Applications of microarrays to renal transplantation: progress and possibilities
    Mei Sze Chua
    Department of Pediatrics, Stanford University School of Medicine, G320, 300 Pasteur Drive, Stanford, CA 94305, USA
    Front Biosci 8:s913-23. 2003
    ..This article will review the current applications of microarray technology in the field of renal transplantation, and discuss the potential impact of this technology on transplantation medicine...
  11. ncbi request reprint Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling
    Minnie Sarwal
    Department of Pediatrics, Stanford University, Stanford, Calif, USA
    N Engl J Med 349:125-38. 2003
    ..We hypothesized that previously unrecognized molecular heterogeneity might underlie some of the variability in the clinical course of acute renal allograft rejection and in its response to treatment...
  12. ncbi request reprint Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells
    Yong Tae Ahn
    Departments of Pediatrics, Stanford University School of Medicine, 300 Pasteur Dr Stanford, CA 94305, USA
    Int J Oncol 37:1627-38. 2010
    ....
  13. pmc Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo
    Xinrui Yan
    Asian Liver Center, Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    Mol Cancer 7:19. 2008
    ..In this study, we validated the over-expression of CDC25B in HCC, and further investigated its potential as a therapeutic target for the management of HCC...
  14. pmc Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes
    Ping Zhao
    Department of Digestive, China Japan Union Hospital, Jilin University, Changchun, Jilin 130033, China
    Biomed Res Int 2013:759057. 2013
    ..Thus, affibody-based PET imaging of EGFR provides a promising approach for detecting HCC in vivo...
  15. pmc Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma
    Lihong Bu
    Department of Radiology, the Fourth Hospital of Harbin Medical University, Heilongjiang, China
    Contrast Media Mol Imaging 7:363-72. 2012
    ..The success of this study suggests that, by improving the synthetic approach and by tuning the surface properties of IONPs, one can arrive at better formulas than Feridex for clinical practice...
  16. pmc In vivo MRSI of hyperpolarized [1-(13)C]pyruvate metabolism in rat hepatocellular carcinoma
    Moses M Darpolor
    Department of Radiology, Stanford University, Stanford, CA 94305 5488, USA
    NMR Biomed 24:506-13. 2011
    ....
  17. ncbi request reprint Microarrays: new tools for transplantation research
    Mei Sze Chua
    Department of Pediatrics, Stanford University School of Medicine, G320, 300 Pasteur Drive, CA 94305, Stanford, USA
    Pediatr Nephrol 18:319-27. 2003
    ....
  18. ncbi request reprint Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma
    Chee Wai Fong
    Signal Transduction Laboratory, Institute of Molecular and Cell Biology, Proteos, Singapore
    Cancer Res 66:2048-58. 2006
    ....
  19. ncbi request reprint Sprouty and cancer: the first terms report
    Ting Ling Lo
    Signal Transduction Laboratory, Institute of Molecular and Cell Biology, 61 Biopolis Drive, 6 01, Proteos, Singapore, 138673
    Cancer Lett 242:141-50. 2006
    ....
  20. ncbi request reprint An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma
    Mohini A Patil
    Department of Biopharmaceutical Sciences, University of California, San Francisco, CA 94143, USA
    Oncogene 24:3737-47. 2005
    ..This approach of integrating other biological information with gene expression in the analysis helps select aberrantly expressed genes in HCC that may be further studied for their diagnostic or therapeutic utility...
  21. ncbi request reprint Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells
    Chen Yao
    Division of Breast Surgery, Department of Surgery, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou, People s Republic of China
    Int J Cancer 121:1949-57. 2007
    ....